DEBORAH PARLETT: Open Payments
NPI 1508917832 · MAYS LANDING, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,529 in 51 payments from 18 companies in 2025. Trend: 2023 $872 · 2024 $1,190 · 2025 $1,529
Food & beverage: $1,484Education: $45
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $229 |
| Aimmune Therapeutics, Inc. | 2 | $199 |
| Lilly USA, LLC | 6 | $188 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $162 |
| Amgen Inc. | 5 | $156 |
| ABBVIE INC. | 3 | $138 |
| Corcept Therapeutics | 5 | $88 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $79 |
| Koya Medical, Inc. | 1 | $49 |
| Abbott Laboratories | 2 | $40 |
Products named: ZENPEP, Kerendia, BREZTRI, REPATHA, MOUNJARO, VRAYLAR, JARDIANCE, Korlym.
Industry payments across NJ — which companies pay providers there.
